Isaacs Sonia R, Foskett Dylan B, Maxwell Anna J, Ward Emily J, Faulkner Clare L, Luo Jessica Y X, Rawlinson William D, Craig Maria E, Kim Ki Wook
Faculty of Medicine and Health, School of Women's and Children's Health, University of New South Wales, Sydney, NSW 2031, Australia.
Virology Research Laboratory, Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Microorganisms. 2021 Jul 16;9(7):1519. doi: 10.3390/microorganisms9071519.
For over a century, viruses have left a long trail of evidence implicating them as frequent suspects in the development of type 1 diabetes. Through vigorous interrogation of viral infections in individuals with islet autoimmunity and type 1 diabetes using serological and molecular virus detection methods, as well as mechanistic studies of virus-infected human pancreatic β-cells, the prime suspects have been narrowed down to predominantly human enteroviruses. Here, we provide a comprehensive overview of evidence supporting the hypothesised role of enteroviruses in the development of islet autoimmunity and type 1 diabetes. We also discuss concerns over the historical focus and investigation bias toward enteroviruses and summarise current unbiased efforts aimed at characterising the complete population of viruses (the "virome") contributing early in life to the development of islet autoimmunity and type 1 diabetes. Finally, we review the range of vaccine and antiviral drug candidates currently being evaluated in clinical trials for the prevention and potential treatment of type 1 diabetes.
一个多世纪以来,病毒留下了一连串的证据,表明它们经常被怀疑与1型糖尿病的发生有关。通过使用血清学和分子病毒检测方法,对患有胰岛自身免疫和1型糖尿病的个体的病毒感染进行深入研究,以及对病毒感染的人类胰腺β细胞进行机制研究,主要嫌疑人已被缩小到主要是人类肠道病毒。在这里,我们全面概述了支持肠道病毒在胰岛自身免疫和1型糖尿病发生中所假设作用的证据。我们还讨论了对肠道病毒的历史关注和调查偏差的担忧,并总结了目前旨在鉴定在生命早期对胰岛自身免疫和1型糖尿病发生有贡献的完整病毒群体(“病毒组”)的无偏差努力。最后,我们回顾了目前正在临床试验中评估的用于预防和潜在治疗1型糖尿病的一系列疫苗和抗病毒药物候选物。